Clinical Trials on Peripheral T-cell Lymphoma in Belgium
Total 282 results
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
MEI Pharma, Inc.TerminatedMarginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Incyte CorporationActive, not recruitingLymphomaBelgium, United States, France, Israel, Italy, United Kingdom, Germany, Spain, Poland, Australia, Argentina, Denmark
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Incyte CorporationActive, not recruitingLymphomaUnited States, Spain, France, United Kingdom, Czechia, Israel, Belgium, Italy, Germany, Poland, Denmark
-
CelgeneCompletedLymphoma, Mantle-Cell | Mantle Cell LymphomaFrance, United Kingdom, Belgium, Spain, Denmark, Germany, Israel, Russian Federation, Italy, Poland, Netherlands, Sweden, Greece, Czechia
-
Seagen Inc.Genentech, Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States, France, Spain, Belgium, Australia, Germany, Poland, Italy, Czech Republic, Hungary
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Italy, Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Poland, United States, United Kingdom, Turkey, Belgium, Thailand, Czechia
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Leukemia, B-cell | Small Lymphocytic Lymphoma | Leukemia, LymphocyticUnited States, Spain, Canada, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, Italy, Czechia, China, Hungary, Israel, Belgium, France, Poland, Germany, Argentina, United Kingdom, Brazil, Turkey, Chile, Austria
-
The Lymphoma Academic Research OrganisationActive, not recruitingMantle Cell LymphomaFrance, Spain, Belgium, Netherlands, Germany, Poland, Portugal
-
CelgeneCompletedMantle Cell LymphomaUnited States, France, Belgium, Austria, Israel, Singapore, Spain, United Kingdom, Hungary, Colombia, Germany, Italy, Turkey, Puerto Rico
-
PfizerCompletedLymphomaCanada, United States, Spain, Austria, Poland, Sweden, China, Belgium, France, Germany, Italy, United Kingdom, Netherlands, Argentina, Switzerland, Chile, Australia, Brazil
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsRecruitingAcute Lymphoblastic Leukemia (ALL)United Kingdom, Australia, Austria, Belgium, Czechia, Denmark, Finland, France, Israel, Italy, Netherlands, Norway, Poland, Portugal, Sweden
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, Belgium, France, Brazil, Ireland, Czechia, Romania, Portugal, Georgia, Argentina, Poland, Puerto Rico, Austria, Switzerland
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Belgium, Germany, Japan, Netherlands, France, Sweden, Italy, Spain, Switzerland, United Kingdom, Finland
-
BeiGeneActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, China, Taiwan, Belgium, France, United Kingdom, Spain, New Zealand, Australia, Czechia, Italy, Poland, Russian Federation, Sweden, Austria
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMantle Cell LymphomaChina, Belgium, Thailand, United States, Spain, Canada, Colombia, Italy, Morocco, Brazil, Turkey, Chile, Malaysia, Israel, Portugal, Singapore, Russian Federation, Philippines, Tunisia, Austria, Czechia, Germany, Hungary, India, Poland, R... and more
-
Novartis PharmaceuticalsCompletedB-cell Acute Lymphoblastic LeukemiaUnited States, Belgium, Germany, Austria, Canada, Italy, Japan, Norway, Australia, France, Spain
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingMantle Cell LymphomaUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Israel, Turkey, Ukraine, Japan, Canada, Greece, Korea, Republic of, Netherlands, Brazil, Russian Federation, Puerto Rico, Australia, I... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada, United States, Korea, Republic of, Australia, China, Taiwan, Spain, Italy, United Kingdom, Japan, Ireland, Denmark, Hungary, Poland, Czechia, France, Israel, Singapore, Belgium, Sweden, Germany, Switzerland
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Hungary, Italy, Poland, Portugal, Germany, Mexico, Romania, Australia, Uk... and more
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsCompletedAcute Lymphoblastic Leukemia (ALL)United Kingdom, Norway, Germany, Italy, France, Belgium, Denmark, Australia, Austria, Czechia, Finland, Israel, Japan, Netherlands, Poland, Portugal, Switzerland
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Spain, Belgium, Austria, Czechia, Australia, Italy, Japan, Hungary, United Kingdom, Taiwan, Turkey, Germany, Canada, France, Israel, Poland, Croatia, Korea, Republic of, Ireland, Russian Federation, Singapore, Sw...
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Bristol-Myers SquibbPfizerCompletedLymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada, Mexico, Belgium, Russian Federation, Hungary, Korea, Republic of, Australia, Puerto Rico, Czechia, New Zealand, Poland
-
Prof. Christina PetersAmgenTerminatedMinimal Residual Disease | ALL, ChildhoodNorway, Spain, Denmark, Austria, Belgium, Czechia, France, Italy, Poland, Slovakia
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Dutch Childhood Oncology GroupCompletedLeukemiaUnited States, United Kingdom, Belgium, Italy, Germany, Austria, Ireland, Netherlands, France, Sweden, Czech Republic
-
Universitaire Ziekenhuizen KU LeuvenUnknownNeurofibromatosis Type 1Belgium
-
CelgeneCompletedLymphoma | Lymphoma, Large B-Cell, Diffuse | Glioblastoma | Multiple Myeloma | Primary Central Nervous System Lymphoma | Pleiotropic Pathway ModifierUnited States, Spain, Belgium, France, Italy
-
Advancell - Advanced In Vitro Cell Technologies...Nexus Oncology LtdCompletedLeukemia, B-Cell, ChronicSpain, France, Belgium
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingLymphoma, Mantle-CellUnited States, China, Spain, Belgium, Canada, Australia, Czechia, Italy, Taiwan, Germany, Japan, New Zealand, United Kingdom, Denmark, Brazil, Israel, France, Netherlands, Korea, Republic of, Poland, Hungary, Austria, Switzerland, Por... and more
-
AbbVieActive, not recruitingAcute Myeloid Leukemia | Cancer | Multiple Myeloma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States, Australia, Belgium, Canada, Denmark, France, Greece, Hong Kong, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Au...
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States, Canada, Netherlands, Germany, Belgium, United Kingdom
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Germany, Belgium, United Kingdom
-
Assistance Publique - Hôpitaux de ParisImagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...RecruitingAcute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in RemissionFrance, Germany, Belgium
-
GenmabAbbVieRecruitingNon-hodgkin LymphomaUnited States, Australia, France, Israel, Korea, Republic of, Spain, Taiwan, Japan, Italy, Belgium, Germany, Canada, Turkey, Czechia
-
Merck KGaA, Darmstadt, GermanyCompletedChronic Lymphocytic Leukemia | Advanced Solid TumorsBelgium, Netherlands, Denmark
-
Kiadis PharmaCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeCanada, Belgium, Germany, Croatia, United Kingdom, Portugal
-
Novartis PharmaceuticalsTerminatedIn Escalation: All Patients With Solid Tumors and Lymphoma | In Expansion: Melanoma, Non-small Cell Lung CancerUnited States, Italy, Taiwan, Belgium, Spain, Germany, Japan
-
Universitair Ziekenhuis BrusselRecruitingCovid19 | Peripheral Blood Mononuclear Cells | Complement AbnormalityBelgium